Search Results

Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product.

Sunshine Biopharma Inc. is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora Pharma, has received approval for its first Biosimilar product.

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.

Sunshine Biopharma Inc. today announced that it has completed the acquisition of all the outstanding shares of Nora Pharma Inc., effective immediately.

Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.

Zai Lab Limited announced that the final overall survival data from the Phase 3 randomized, double-blind, placebo-controlled NORA study evaluating ZEJULA® in Chinese patients with platinum-sensitive recurrent ovarian cancer will be shared in oral presentations at the 2024 Congress of the European Society of Gynaecological Oncology and the 2024 Society for Gynecologic Oncology Annual Meeting on Women’s Cancer.

Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.

A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.